Joincare Pharmaceutical Group Industry Co., Ltd

This Phase 2a study tested an inhaled drug called JKN2304 in 42 adults with moderate-to-severe COPD. Participants received either JKN2304, a placebo, or an active comparator (formoterol) for 14 days. The main goal was to check safety, and researchers also measured changes in lung…

This early-stage study tested a single dose of an inhaled drug called DBM-1152A in 44 healthy Chinese adults. The main goal was to see if the drug is safe and how the body processes it. No treatment was given for any disease; the study simply gathered safety information to guide …

This early-phase trial tested the safety and tolerability of an inhaled drug called DBM-1152A in 20 healthy Chinese adults. Participants received either the drug or a placebo once daily for 7 days at different dose levels. The study focused on side effects and how the drug moves …

This early-stage study tested a new drug called JKN2306 in 44 healthy adults in China. The main goal was to see if single doses are safe and how the body processes the drug, including the effect of food. This trial does not test whether the drug actually relieves pain.